Clinical Trial Update: Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the effect of food on the pharmacokinetics of LPM3770164 sustained-release tablets. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease
• Tardive Dyskinesia

Drugs mentioned

• LPM3770164

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Huntington Disease, Tardive Dyskinesia | Phase 1 | Status: COMPLETED